THE EFFECT OF CHIROPRACTIC THORACIC MANIPULATION ON PAIN, DEPRESSION, SLEEP AND QUALITY OF LIFE IN PATIENTS WITH FIBROMYALGIA
Key facts
- Who runs it
- Bahçeşehir University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 1 Jul 2023
- Ended
- 25 Aug 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- chiropractic manipulation
- sham manipulation
- Record updated
- 9 October 2024
Who can take part
- Age
- 25 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Having been diagnosed with fibromyalgia by a doctor
- Having good cognitive status
- Willingness to participate in the study voluntarily
- Being a female aged between 25 and 45
- The symptoms persisting without any degree of improvement or decrease recently
- Having dysfunction (limited movement) in the thoracic region
- Having no condition that would prevent high-velocity low-amplitude (HVLA) manipulation
Who cannot take part
- Receiving any non-pharmacological treatment
- Having heart, kidney, or liver failure
- Having inflammatory, psychiatric, neurological, and/or chronic progressive systemic diseases
- Having a history of acute or past fractures
- Malignancy history
- Having a history of thoracic surgery
- Metabolic bone diseases
- Infection, fever, hypotension, respiratory disorders limiting treatment application
- Having a rheumatic disease (except osteoarthritis)
- Pregnancy
- Having thoracic hernias, radiculopathy, motor deficits spondylosis, spondylolisthesis, narrow canal, extruded hernia, disc herniation, discitis diagnoses
- Osteoporosis
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aimed to investigate the effects of thoracic chiropractic manipulations on pain intensity, depression levels, sleep, and quality of life in women diagnosed with fibromyalgia. The research included 50 female participants aged 25-45 who had been diagnosed with fibromyalgia between 2022 and 2023 at Şişli Hamidiye Etfal Education and Research Hospital. The participants were randomly divided into two groups: a chiropractic treatment group and a control group. Both groups completed pre-treatment assessments using the Visual Analog Scale (VAS), Beck Depression Inventory (BDI), Pittsburgh Sleep Quality Index (PSQI), and Short Form 36 (SF-36). The chiropractic treatment group received thoracic chiropractic manipulations (HVLA) twice a week for a total of six sessions over three weeks, while the control group received sham manipulations. A week after the final session, all participants completed the assessments again.
The 2 groups in the trial
- Treatment GroupTreatment being tested
Treatment: chiropractic manipulation
- Control GroupSham treatment, for comparison
Treatment: sham manipulation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 9 October 2024